Diridavumab (CR6261) (INN) is a monoclonal antibody designed for the treatment of influenza A.Statement On A Nonproprietary Name Adopted By The USAN Council -…
Diridavumab (CR6261) (INN) is a monoclonal antibody designed for the treatment of influenza A.Statement On A Nonproprietary Name Adopted By The USAN Council - Diridavumab, American Medical Association.
This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson.
References
Gebaseerd op: Wikipedia — Diridavumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.